(1) Whether transcriptomic characterization of CD4 and CD8 T‐cell subsets is consistent across TB patients. (2) Whether connectivity between cell subpopulations shows a similar pattern across TB patients. (3) Whether the findings can be validated and replicated in a larger sample group. Here, CD4 is linked to tuberculosis.